Oberweis Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$561K Buy
2,294
+244
+12% +$56.8K 0.02% 157
2025
Q4
$424K Buy
2,050
+3
+0.1% +$593 0.02% 167
2025
Q3
$380K Sell
2,047
-52
-2% -$8.91K 0.01% 175
2025
Q2
$321K Sell
2,099
-20
-0.9% -$3.07K 0.01% 177
2025
Q1
$351K Buy
2,119
+2
+0.1% +$313 0.02% 181
2024
Q4
$306K Buy
2,117
+4
+0.2% +$620 0.01% 189
2024
Q3
$342K Sell
2,113
-58
-3% -$9.24K 0.02% 196
2024
Q2
$317K Buy
2,171
+4
+0.2% +$595 0.02% 187
2024
Q1
$343K Buy
2,167
+2
+0.1% +$318 0.02% 183
2023
Q4
$339K Sell
2,165
-368
-15% -$56.4K 0.03% 181
2023
Q3
$395K Sell
2,533
-178
-7% -$29.4K 0.04% 180
2023
Q2
$449K Buy
2,711
+3
+0.1% +$484 0.05% 167
2023
Q1
$420K Buy
2,708
+3
+0.1% +$484 0.07% 156
2022
Q4
$478K Buy
2,705
+2
+0.1% +$345 0.1% 151
2022
Q3
$442K Buy
2,703
+3
+0.1% +$508 0.1% 149
2022
Q2
$479K Buy
2,700
+12
+0.4% +$2.14K 0.12% 117
2022
Q1
$476K Buy
2,688
+2
+0.1% +$340 0.1% 115
2021
Q4
$459K Sell
2,686
-86
-3% -$14.1K 0.08% 116
2021
Q3
$448K Buy
2,772
+282
+11% +$48.1K 0.09% 115
2021
Q2
$410K Buy
2,490
+3
+0.1% +$497 0.09% 113
2021
Q1
$409K Buy
2,487
+3
+0.1% +$485 0.08% 122
2020
Q4
$391K Buy
2,484
+3
+0.1% +$443 0.1% 102
2020
Q3
$369K Buy
2,481
+3
+0.1% +$444 0.12% 94
2020
Q2
$349K Buy
2,478
+72
+3% +$10.5K 0.14% 102
2020
Q1
$315K Buy
2,406
+3
+0.1% +$426 0.17% 125
2019
Q4
$350K Sell
2,403
-247
-9% -$33.5K 0.12% 160
2019
Q3
$343K Sell
2,650
-93
-3% -$12.3K 0.08% 161
2019
Q2
$382K Buy
2,743
+4
+0.1% +$554 0.07% 159
2019
Q1
$383K Buy
2,739
+3
+0.1% +$402 0.08% 158
2018
Q4
$353K Buy
2,736
+289
+12% +$40.3K 0.08% 163
2018
Q3
$338K Sell
2,447
-48
-2% -$6.38K 0.07% 176
2018
Q2
$303K Sell
2,495
-64
-3% -$7.99K 0.08% 192
2018
Q1
$328K Sell
2,559
-40
-2% -$5.41K 0.09% 195
2017
Q4
$363K Sell
2,599
-314
-11% -$43.7K 0.08% 191
2017
Q3
$379K Buy
2,913
+198
+7% +$26.2K 0.11% 122
2017
Q2
$359K Buy
2,715
+123
+5% +$15.7K 0.1% 118
2017
Q1
$323K Sell
2,592
-45
-2% -$5.38K 0.1% 116
2016
Q4
$304K Buy
2,637
+1
+0% +$116 0.09% 111
2016
Q3
$311K Sell
2,636
-499
-16% -$60.5K 0.09% 116
2016
Q2
$380K Buy
3,135
+3
+0.1% +$341 0.11% 126
2016
Q1
$339K Buy
3,132
+3
+0.1% +$311 0.1% 146
2015
Q4
$321K Sell
3,129
-39
-1% -$3.92K 0.09% 154
2015
Q3
$296K Buy
3,168
+3
+0.1% +$290 0.09% 139
2015
Q2
$308K Sell
3,165
-297
-9% -$29.7K 0.08% 144
2015
Q1
$348K Sell
3,462
-16
-0.5% -$1.63K 0.1% 135
2014
Q4
$364K Sell
3,478
-498
-13% -$52.5K 0.11% 94
2014
Q3
$424K Buy
3,976
+2
+0.1% +$207 0.12% 88
2014
Q2
$416K Sell
3,974
-398
-9% -$40.2K 0.1% 109
2014
Q1
$429K Buy
4,372
+5
+0.1% +$464 0.09% 115
2013
Q4
$400K Sell
4,367
-42
-1% -$3.87K 0.1% 104
2013
Q3
$382K Sell
4,409
-99
-2% -$8.88K 0.11% 95
2013
Q2
$387K Buy
+4,508
New +$383K 0.11% 116

Other funds holding JNJ

Oberweis Asset Management's JNJ Position: Q1 2026 in Review

Oberweis Asset Management increased its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, buying an estimated $56.8K and bringing the position to 2,294 shares worth $561K. The position accounts for 0.02% of the portfolio, ranked #157.

Oberweis Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Oberweis Asset Management held 2,294 shares of Johnson & Johnson worth $561K as of Q1 2026.
  • Oberweis Asset Management bought 244 Johnson & Johnson shares in Q1 2026, an estimated $56.8K.
  • Johnson & Johnson made up 0.02% of Oberweis Asset Management's portfolio in Q1 2026, its #157 holding.
  • Oberweis Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.